Targeting CD27 Boosts Vaccine-induced Immune Memory
A recent study shows that CD27 agonism can improve the efficacy and durability of vaccine-induced antitumor responses in HER2+ breast cancer. The outcomes may pave the way for approaches to improve the efficacy and durability of tumor antigen vaccines.
Publication Details
- Journal
- Cancer Discovery
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1158/2159-8290.cd-nw2026-0004
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00